Tomasz S.
- Country
- Poland
- Department
- #311 Oddzial w Czestochowie
Research Overview
- Efficacy and Safety Evaluation of Deucravacitinib in Biologic-Naïve Patients with Active Psoriatic Arthritis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Compared to Denosumab in Post-Menopausal Osteoporosis Patients
- Evaluation of Efficacy, Safety, Pharmacokinetics, and Immunogenicity of LY06006 Versus Denosumab in Postmenopausal Osteoporosis: A Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 19 of 124 partner sites.
Specializations
Bone Health Research
The investigator specializes in the treatment of postmenopausal osteoporosis, conducting extensive research in bone density management and therapeutic interventions. Their work focuses on evaluating novel treatments and biosimilar medications for osteoporosis management.
- Bone Mineral Density Assessment
- Osteoporosis Treatment Development
- Postmenopausal Health Management
Primary focus includes bone density measurement techniques and evaluation of bone resorption markers.
Rheumatology Studies
The investigator conducts research in psoriatic arthritis treatment, particularly focusing on novel therapeutic approaches for patients who haven't previously received biological treatments.
- Inflammatory Arthritis Management
- Disease-Modifying Treatments
- Autoimmune Conditions
Specialized interest in evaluating innovative therapeutic agents for active psoriatic arthritis.
Therapeutic Development
The investigator's expertise extends to pharmacodynamic assessment and biosimilar development, with particular emphasis on comparative efficacy studies and treatment safety profiles.
- Therapeutic Equivalence Studies
- Immunogenicity Assessment
- Biomarker Analysis
Focuses on evaluating biological markers and treatment responses in chronic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.